8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Analyze DCF forecasts for the company and compare them with competitors.
755.41B
Revenue has increased from the previous period.
3.99%
Revenue growth rate has decreased from the previous period.
44.91B
EBITDA has decreased from the previous period.
5.94%
EBITDA margin has decreased from the previous period.
29.80B
EBIT has decreased from the previous period.
3.94%
EBIT margin has decreased from the previous period.
15.11B
Depreciation has increased from the previous period.
37.36B
Total cash has decreased from the previous period.
4.95%
Cash percentage has decreased from the previous period.
198.00M
Receivables have increased from the previous period.
0.03%
Receivables percentage has increased from the previous period.
66.36B
Inventories have increased from the previous period.
8.78%
Inventory percentage has increased from the previous period.
139.22B
Accounts payable has increased from the previous period.
18.43%
Payables percentage has increased from the previous period.
-43.50B
Capital expenditure has increased from the previous period.
-5.76%
CapEx percentage has increased from the previous period.
5.07%
WACC is unchanged from the previous period.
5.18%
Cost of equity is unchanged from the previous period.
3.99%
Cost of debt is unchanged from the previous period.
0.25
Beta is unchanged from the previous period.
79.24M
Diluted shares outstanding is unchanged from the previous period.
34.06B
Total debt is unchanged from the previous period.
696.60B
Total equity is unchanged from the previous period.
730.66B
Total capital is unchanged from the previous period.
4.66%
Debt weighting is unchanged from the previous period.
95.34%
Equity weighting is unchanged from the previous period.
20.88B
EBIAT has decreased from the previous period.
-7.24B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
379.47B
Terminal value is unchanged from the previous period.
352.83B
Enterprise value has increased from the previous period.
-18.24B
Net debt is unchanged from the previous period.
371.06B
Equity value has increased from the previous period.
4682.79
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
611.77B
The estimated revenue has increased from the previous period.
38.23B
The estimated EBITDA has increased from the previous period.
236.19
The estimated EPS has increased from the previous period.
18.72B
The estimated net income has increased from the previous period.
25.95B
The estimated EBIT has increased from the previous period.
86.56B
The estimated SG&A expenses have increased from the previous period.
